(Q34779001)

4 August 2017

1 reference

title

Review of antifungal therapy and the severity index for assessing onychomycosis: part I. (English)

1 reference

4 August 2017

Robert Baran

1

1 reference

4 August 2017

Rod J Hay

series ordinal

2

1 reference

4 August 2017

Javier I Garduno

series ordinal

3

1 reference

4 August 2017

publication date

1 January 2008

1 reference

Journal of Dermatological Treatment

4 August 2017

published in

1 reference

4 August 2017

volume

19

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

72-81

1 reference

Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Agar sublimation test for the in vitro determination of the antifungal activity of morpholine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

New insights into the effect of amorolfine nail lacquer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Partial surgical avulsion of the nail in onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Combination of fluconazole and urea in a nail lacquer for treating onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Resistance of Candida species to fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Terbinafine: mode of action and properties of the squalene epoxidase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Taste loss to terbinafine: a case-control study of potential risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Treatment of Candida nail infection with terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Terbinafine in onychomycosis with involvement by non-dermatophytic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Sensitivity of fungi isolated from onychomycosis to Eugenia cariophyllata essential oil and eugenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Antifungal effect of 5-aminolevulinic acid PDT in Trichophyton rubrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701243418

10.1080/09546630701243418

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference